RBM Partnership Welcomes New Commitments To Malaria Innovation, Including mRNA Platform And Local Manufacturing For Malaria Vaccine
The RBM Partnership to End Malaria welcomes the announcement today of a major project by kENUP Foundation and BioNTech to develop the first mRNA-based prophylactic malaria vaccine.… Read More »RBM Partnership Welcomes New Commitments To Malaria Innovation, Including mRNA Platform And Local Manufacturing For Malaria Vaccine